Essais liés9clinical trials
VilleCamperdownlocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05716100

Ouvrir le site du centre

Essais cliniques associés

9
MoléculeIndication / populationPhaseNCTTitreStatut
RO7568282 Alzheimer Phase 2 NCT07781657 TARBELA-AD — Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease RECRUITING
WiSE System Insuffisance cardiaque Non applicable NCT02922036 SOLVE-CRT — Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients ACTIVE_NOT_RECRUITING
Pulsed Field (PF) /Radiofrequency (RF) Catheter ablation Maladie coronarienne Non applicable NCT06272981 PulseSmart — A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS COMPLETED
XEN1101 Épilepsie Phase 3 NCT05716100 A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) RECRUITING
Trontinemab Alzheimer Phase 3 NCT07717411 PrevenTRON — A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease RECRUITING
Vicadrostat Hypertension Phase 3 NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease RECRUITING
Trontinemab Alzheimer Phase 3 NCT07170150 TRONTIER 2 — A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease ACTIVE_NOT_RECRUITING
XEN1101 Épilepsie Phase 3 NCT05718817 X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy ENROLLING_BY_INVITATION
BHV-7000 Épilepsie Phase 2/3 NCT06309966 RISE 3 — Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy ACTIVE_NOT_RECRUITING